We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$4.02B
1-Year Est. Return
215.74%
This Fund
S&P 500
This Quarter
Est. Return
+53.23%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.17B
AUM Growth
+$643M
(+42%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
95.29%
Holding
25
New
–
Increased
–
Reduced
4
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vir Biotechnology
VIR
|
+$57.1M |
| 2 |
CrowdStrike
CRWD
|
+$11.2M |
| 3 |
Fulcrum Therapeutics
FULC
|
+$692K |
| 4 |
Lyft
LYFT
|
+$14.4K |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
+$12.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.64% |
| 2 | Consumer Discretionary | 37.91% |
| 3 | Technology | 21.88% |
| 4 | Communication Services | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
JD.com
JD
$40.8B
| $816M | 37.64% |
13,553,474
| – | – |
|
|
2
Lyft
LYFT
$5.39B
| $423M | 19.54% |
12,828,509
-455
| -0% | -$14.4K |
|
3
DexCom
DXCM
$27.6B
| $327M | 15.07% |
3,222,724
| – | – |
|
|
ONEM
4
DELISTED
1Life Healthcare
ONEM
| $225M | 10.36% |
6,183,154
| – | – |
|
5
Arcus Biosciences
RCUS
$3.57B
| $125M | 5.77% |
5,049,786
| – | – |
|
6
Schrodinger
SDGR
$1.12B
| $41.1M | 1.9% |
448,722
| – | – |
|
|
WORK
7
DELISTED
Slack Technologies, Inc.
WORK
| $40.4M | 1.87% |
1,299,771
| – | – |
|
8
Dianthus Therapeutics
DNTH
$5.68B
| $25.1M | 1.16% |
208,696
| – | – |
|
|
RAPT
9
DELISTED
RAPT Therapeutics
RAPT
| $24.3M | 1.12% |
104,507
| – | – |
|
10
Beam Therapeutics
BEAM
$2.58B
| $18.6M | 0.86% |
663,691
| – | – |
|
11
Spero Therapeutics
SPRO
$68.9M
| $15.1M | 0.69% |
1,112,473
| – | – |
|
|
12
Fulcrum Therapeutics
FULC
$248M
| $12.5M | 0.58% |
682,240
-43,949
| -6% | -$692K |
|
13
Snap
SNAP
$7.32B
| $12.3M | 0.57% |
523,710
| – | – |
|
|
AUTL
14
Autolus Therapeutics
AUTL
$386M
| $11.2M | 0.52% |
698,262
-1,090
| -0.2% | -$12.1K |
|
15
IDEAYA Biosciences
IDYA
$3.41B
| $10.7M | 0.49% |
753,187
| – | – |
|
16
Quince Therapeutics
QNCX
$17.5M
| $8.76M | 0.4% |
946
| – | – |
|
|
GRTS
17
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $6.17M | 0.28% |
929,022
| – | – |
|
18
Aterian
ATER
$4.35M
| $5.8M | 0.27% |
87,996
| – | – |
|
|
CLDR
19
DELISTED
Cloudera, Inc.
CLDR
| $5.44M | 0.25% |
427,710
| – | – |
|
|
EVLO
20
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $5.2M | 0.24% |
53,025
| – | – |
|
21
Alector
ALEC
$164M
| $4.3M | 0.2% |
175,866
| – | – |
|
|
22
CrowdStrike
CRWD
$187B
| $3.11M | 0.14% |
124,080
-560,000
| -82% | -$11.2M |
|
23
Uber
UBER
$134B
| $1.29M | 0.06% |
41,585
| – | – |
|
24
Dropbox
DBX
$6.81B
| $284K | 0.01% |
13,033
| – | – |
|
|
25
Vir Biotechnology
VIR
$1.47B
| – | – |
-1,666,666
| Closed | -$57.1M |
|
Similar funds
JSW
BWA
MAM
GCM
USCWA
ICP
CA
MGP
Alphabet Inc's Q2 2020 Portfolio in Review
As of Q2 2020, Alphabet Inc held 25 positions worth $2.17B, up 42% from $1.52B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Alphabet Inc withdrew a net $69.1M in Q2 2020, closing 1 position and reducing 4 holdings. Its most notable exit was Vir Biotechnology, an estimated $57.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Technology.
- Alphabet Inc's biggest Q2 2020 reduction was CrowdStrike, cutting an estimated $11.2M.
- Alphabet Inc fully exited Vir Biotechnology in Q2 2020, selling an estimated $57.1M.
- Alphabet Inc's ten largest holdings make up 95% of its $2.17B portfolio in Q2 2020.
- Alphabet Inc opened 0 new positions and closed 1 in Q2 2020.
- Alphabet Inc's portfolio value rose 42% quarter-over-quarter to $2.17B.
Based on Alphabet Inc's 13F filing for Q2 2020, filed 15 Nov 2022.